Related Experiment Video
Updated: Mar 30, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
Expression profiling reveals transcriptional regulation by Fbxw7/mTOR pathway in radiation-induced mouse thymic
Antoine M Snijders1, Yueyong Liu1,2, Li Su1
1Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, CA, USA.
Abstract:
The tumor suppressor gene FBXW7 is deleted and mutated in many different types of human cancers. FBXW7 primarily exerts its tumor suppressor activity by ubiquitinating different oncoproteins including mTOR. Here we used gene transcript profiling to gain a deeper understanding of the role of FBXW7 in tumor development and to determine the influence of mTOR inhibition by rapamycin on tumor transcriptome and biological functions. In comparison to tumors from p53 single heterozygous (p53+/-) mice, we find that radiation-induced thymic lymphomas from Fbxw7/p53 double heterozygous (Fbxw7+/-p53+/-) mice show significant deregulation of cholesterol metabolic processes independent of rapamycin treatment, while cell cycle related genes were upregulated in tumors from placebo treated Fbxw7+/-p53+/- mice, but not in tumors from rapamycin treated Fbxw7+/-p53+/- mice. On the other hand, tumors from rapamycin treated Fbxw7+/-p53+/- mice were enriched for genes involved in the integrated stress response, an adaptive mechanism to survive in stressful environments. Finally, we demonstrated that the Fbxw7 gene signatures identified in mouse tumors significantly overlap with FBXW7 co-expressed genes in human cancers. Importantly these common FBXW7 gene signatures between mouse and human are predictive for disease-free survival in human colon, breast and lung adenocarcinoma cancer patients. These results provide novel insights into the role of FBXW7 in tumor development and have identified a number of potential targets for therapeutic intervention.
Insights
The tumor suppressor FBXW7 (F-box and leucine-rich repeat protein with WD40 repeats 7) gene impacts cancer development. Its gene signatures in mouse models predict patient survival, offering potential therapeutic targets.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The FBXW7 gene is a crucial tumor suppressor, frequently altered in human cancers.
- FBXW7 regulates oncoproteins like mTOR through ubiquitination, impacting cell growth and survival.
- Understanding FBXW7's role is vital for developing targeted cancer therapies.
Purpose of the Study:
- To investigate the role of FBXW7 in tumor development using gene transcript profiling.
- To assess the impact of mTOR inhibition by rapamycin on tumor gene expression and biological functions.
- To identify conserved FBXW7 gene signatures between mouse models and human cancers.
Main Methods:
- Gene transcript profiling of radiation-induced thymic lymphomas in Fbxw7/p53 double heterozygous mice.
- Comparison of gene expression in tumors with and without rapamycin treatment.
- Analysis of conserved gene signatures and their correlation with patient survival data.
Main Results:
- Fbxw7/p53 heterozygous tumors showed deregulation of cholesterol metabolism, independent of rapamycin.
- Cell cycle genes were upregulated in placebo-treated tumors but not in rapamycin-treated tumors.
- Rapamycin treatment enriched for integrated stress response genes in Fbxw7/p53 heterozygous tumors.
- FBXW7 gene signatures in mouse tumors significantly overlapped with human cancers and predicted disease-free survival.
Conclusions:
- FBXW7 plays a significant role in tumor development, influencing metabolic and cell cycle pathways.
- mTOR inhibition by rapamycin modulates the tumor transcriptome, impacting stress response.
- Conserved FBXW7 gene signatures offer predictive biomarkers for patient survival and potential therapeutic targets in various cancers.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
PI3K/mTOR/AKT Signaling Pathway
Master Transcription Regulators
Abnormal Proliferation
TGF - β Signaling Pathway

